The tweet was deleted by the author.
But we saved everything 🙂.
Definium Therapeutics has announced that its executive team will participate in a fireside chat at the Jefferies Healthcare Conference this Wednesday, June 3.
The session will feature CEO Robert Barrow, CMO Dan Karlin, and CFO Brandi Roberts and is scheduled for 3:10 PM EDT. Attendees of the event are encouraged to listen in as the leadership discusses the company's latest strategies and updates. Details are being clarified.
Definium Therapeutics recently presented pre-clinical safety results for its psychedelic therapy at the APA Annual Meeting. The company also joined leaders at ASCP in Miami Beach to showcase AI-powered advances for psychiatric drug development. Both events highlighted Definium's ongoing efforts in drug innovation.